Jefferies Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Jefferies Group’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,745	Closed	-$64K	–	2958
2019 Q4	$64K	Buy	+19,745	New	+$57.3K	﹤0.01%	2429
2019 Q1	–	Sell	-13,621	Closed	-$40K	–	2871
2018 Q4	$40K	Sell	13,621 -18,904	-58%	-$51.9K	﹤0.01%	2047
2018 Q3	$86K	Sell	32,525 -37,344	-53%	-$91.7K	﹤0.01%	2238
2018 Q2	$163K	Buy	+69,869	New	+$195K	﹤0.01%	2066
2016 Q1	–	Sell	-13,885	Closed	-$49K	–	2882
2015 Q4	$49K	Buy	+13,885	New	+$58.1K	﹤0.01%	2129
2014 Q4	–	Sell	-1,686	Closed	-$13K	–	2682
2014 Q3	$13K	Buy	+1,686	New	+$15.7K	﹤0.01%	2050
2013 Q4	–	Sell	-17,499	Closed	-$139K	–	2504
2013 Q3	$139K	Buy	+17,499	New	+$141K	﹤0.01%	1679

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jefferies Group's PDLI Position: Q1 2020 in Review

Jefferies Group sold out of PDL BioPharma, Inc. (PDLI) in Q1 2020, closing a stake of 19,745 shares — an estimated $64K sold.

Jefferies Group first reported a position in PDLI in Q3 2013 and held it in 7 quarters. The position peaked at $163K in Q2 2018. 132 funds tracked by Wall St. Rank hold PDLI as of Q1 2020.

Jefferies Group reported no remaining PDL BioPharma, Inc. position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 19,745 PDL BioPharma, Inc. shares in Q1 2020, an estimated $64K.
Jefferies Group first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 7 quarters.
Jefferies Group's PDL BioPharma, Inc. position peaked at $163K in Q2 2018.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.